422O - A prospective phase III randomized study to evaluate the efficacy of olanzapine for prevention of nausea and vomiting in patients receiving highly emetogenic chemotherapy (HEC)
| Autor: | Pehalajani, J.K., Govind Babu, K., Lokanatha, D., Jacob, L.A., Suresh Babu, M.C., Lokesh, K.N., Rudresha, A.H., Rajeev, L.K., Smitha, S.C., Giri, G.V. |
|---|---|
| Zdroj: | In Annals of Oncology November 2018 29 Supplement 9:ix129-ix129 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|